Cyproheptadine in Cushing's syndrome. (Record no. 69586)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01180 a2200361 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250510210825.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 197711s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0140-6736 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/s0140-6736(77)92516-8 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Marek, J |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 19771130 |
245 00 - TITLE STATEMENT | |
Title | Cyproheptadine in Cushing's syndrome. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Lancet (London, England) |
Date of publication, distribution, etc. | Sep 1977 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 653-4 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Comparative Study; Letter |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | 17-Hydroxycorticosteroids |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adrenal Cortex Function Tests |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bromocriptine |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cushing Syndrome |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyproheptadine |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Evaluation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Metyrapone |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Stimulation, Chemical |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Matys, Z |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gregorová, I |
773 0# - HOST ITEM ENTRY | |
Title | Lancet (London, England) |
Related parts | vol. 2 |
-- | no. 8039 |
-- | p. 653-4 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/s0140-6736(77)92516-8">https://doi.org/10.1016/s0140-6736(77)92516-8</a> |
Public note | Available from publisher's website |
No items available.